Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-23
DOI
10.1038/s41598-019-50140-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Molecular profiling of ALDH1+ colorectal cancer stem cells reveals preferential activation of MAPK, FAK, and oxidative stress pro-survival signalling pathways
- (2018) Radhakrishnan Vishnubalaji et al. Oncotarget
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular heterogeneity in breast cancer: State of the science and implications for patient care
- (2017) Rachel E. Ellsworth et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Bone morphogenetic protein 2 (BMP2) induces growth suppression and enhances chemosensitivity of human colon cancer cells
- (2016) Radhakrishnan Vishnubalaji et al. Cancer Cell International
- Integrating geochemical (surface waters, stream sediments) and biological (diatoms) approaches to assess AMD environmental impact in a pyritic mining area: Aljustrel (Alentejo, Portugal)
- (2016) Ana Teresa Luís et al. JOURNAL OF ENVIRONMENTAL SCIENCES
- Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt
- (2016) Jinfang Zhang et al. MOLECULAR CELL
- Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
- (2016) Ahmad Barghash et al. Oncotarget
- MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1
- (2016) Radhakrishnan Vishnubalaji et al. Oncotarget
- Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells
- (2016) Dalia Ali et al. Stem Cells Translational Medicine
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- The role of the insulin-like growth factor-1 system in breast cancer
- (2015) Panagiotis F Christopoulos et al. Molecular Cancer
- Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition
- (2015) E Lee et al. Cell Death & Disease
- The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
- (2015) Christian Mayr et al. Oncotarget
- Angiogenic Potential of Human Neonatal Foreskin Stromal Cells in the Chick Embryo Chorioallantoic Membrane Model
- (2015) Radhakrishnan Vishnubalaji et al. Stem Cells International
- Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway
- (2015) Nehad M Alajez et al. Oncotarget
- The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes
- (2014) Sabine Paternot et al. CELL CYCLE
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- ROS Links Glucose Metabolism to Breast Cancer Stem Cell and EMT Phenotype
- (2013) Michael S. Schieber et al. CANCER CELL
- The evolving landscape of glioblastoma stem cells
- (2013) Kenneth Yan et al. CURRENT OPINION IN NEUROLOGY
- Self-renewal as a therapeutic target in human colorectal cancer
- (2013) Antonija Kreso et al. NATURE MEDICINE
- Pleiotropic effects of cancer cells’ secreted factors on human stromal (mesenchymal) stem cells
- (2013) Mashael Al-toub et al. Stem Cell Research & Therapy
- NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells
- (2012) Tewfik Hamidi et al. Autophagy
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- The Golgi in Cell Migration: Regulation by Signal Transduction and Its Implications for Cancer Cell Metastasis
- (2012) Valentina Millarte et al. TheScientificWorldJOURNAL
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy
- (2009) N M Alajez et al. CELL DEATH AND DIFFERENTIATION
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression
- (2008) Catherine Fan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More